Evidence map›Paper›PMID 35126638›Full record

ArticleComputational and mathematical methods in medicine2022

Health Care System View of Human Papilloma Virus (HPV) Vaccine Acceptability by Emirati Men.

Suzan Al Shdefat, Shamsa Al Awar, Nawal Osman, Howaida Khair, Gehan Sallam, Hassan Elbiss

Open access · hybridAbstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Suzan Al ShdefatFaculty of Medicine-Jordan University of Science and Technology, King Abdulla University Hospital, UAE.ORCID https://orcid.org/0000-0001-7014-5430
Shamsa Al AwarChair of Obstetrics & Gynecology Department, College of Medicine & Health Sciences (CMHS), United Arab Emirates University (UAEU), Al Ain, UAE.ORCID https://orcid.org/0000-0002-0452-7024
Nawal OsmanObstetrics and Gynecology Department, CMHS, UAEU, Al Ain, UAE.ORCID https://orcid.org/0000-0003-1362-4093
Howaida KhairObstetrics and Gynecology Department, CMHS, UAEU, Al Ain, UAE.
Gehan SallamObstetrics and Gynecology Department, CMHS, UAEU, Al Ain, UAE.
Hassan ElbissCMHS, UAEU, Al Ain, UAE.
United Arab Emirates University · AEJordan University of Science and Technology · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This is the most frequent sexually transmitted illness on the planet, and both men and women are equally vulnerable. HPV is associated with a broad variety of female disorders, including 99 percent of all cervical cancer cases. Specifically, the goal and contributions of this study are to determine Emirati men's opinions about the HPV vaccination, specifically whether they would use it themselves or allow their female relatives to use the vaccine. To collect the primary data, a statistical cross-sectional survey was conducted. This quantitative study was conducted using primary sources of data. A questionnaire survey with a sample size of 390 participants was used to collect data from 400 individuals. Male university students in the United Arab Emirati men have a weak grasp of HPV and are averse to vaccination (Ortashi et al., 2013). The percentage of Emirati men who accept the HPV vaccination is 37%. A total of 40.3% of the respondents opted not to participate in the survey at all. Eighty-six percent of the women surveyed had heard of cervical cancer, and one-third believed that they were at risk in the future. Twenty-five percent of those surveyed said that the HPV vaccination was safe, while 26% said it was unsafe. Respondents were just 3.1 percent vaccinated, and their family members were only 87% not vaccinated.

Indexed as

Papillomavirus VaccinesAttitude to HealthComputational BiologyCross-Sectional StudiesFamilyFemaleHumansImmunization ProgramsMalePapillomavirus InfectionsPatient Acceptance of Health CareSurveys and QuestionnairesUnited Arab EmiratesUterine Cervical NeoplasmsVaccination HesitancyVaccination RefusalPapillomavirus Vaccines

Identifiers

PMID35126638
PMCPMC8816567
OpenAlexW4210645161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.